Feasibility of a Novel Technique for Pilonidal Wound Healing

Status Recruiting

Clinical Trial Summary

Pilonidal disease (PD) is a chronic disease with a major impact on patient quality of life and productivity. Thus, wound healing would have a significant effect on patient quality outcomes, patient quality of life, and healthcare utilization, as well as societal benefits from allowing this vital population to return to productivity. There is no consensus on postoperative wound care after surgery for PD. Negative pressure therapy is commonly used. However, this therapy is costly and cumbersome, and not evidence-based to optimize wound healing or postoperative patient or financial outcomes. The investigators goal is to investigate the impact of MatriStem® Wound Matrix and MicroMatrix® (ACell, Inc., Columbia, MD) on pilonidal wound healing. Secondary goals are to evaluate the impact of MatriStem Wound Matrix and MicroMatrix on postoperative outcomes, quality of life, and healthcare costs after surgical management of pilonidal disease.

Clinical Trial Description

The investigators study has 2 main goals:

Aim 1: To evaluate wound healing at 2 weeks, 1 month, 3 months, and 6 months postoperatively in a prospective MatriStem Wound Matrix and MicroMatrix cohort

Aim 2: To evaluate pilonidal recurrence, reoperation rates, healthcare utilization, and quality of life at 2 weeks, 1 month, 3 months, and 6 months postoperatively in a prospective MatriStem Wound Matrix and MicroMatrix cohort

The investigators main hypothesis is that using MatriStem Wound Matrix and MicroMatrix for postoperative wound care will significantly improve healing rates, healthcare utilization, and quality of life outcomes. The null hypothesis of the study is that there is no significant difference in healing rates, healthcare utilization, and quality of life outcomes between MatriStem Wound Matrix/ MicroMatrix and negative pressure dressing cohorts. The alternative hypothesis is that there are differences in healing rates, healthcare utilization, and quality of life outcomes between MatriStem Wound Matrix/ MicroMatrix and negative pressure dressing cohorts.

Twenty consecutive patients undergoing surgical excision for Pilonidal Disease will be recruited for treatment. All patients will undergo comparable surgical excision and application of the novel protocol. The wound will be left undisturbed for 10-14 days (until the 1st follow-up visit). At the 1st scheduled postoperative visit, the wound will reassessed in the operative suite, and a second application of the protocol may be performed at the surgeon's discretion. The next follow-up visits will be at 1 month, 3 months, and 6 months. At these visits, the wound bed will be measured, photo documentation will be captured, and patients will complete a survey to assess quality of life.

Study Endpoints are:

1. Wound healing at 6 months. Success is defined at a 60% healing rate of epithelialization and wound contracture by volume measurements in centimeters.

2. Observation of quality of life, total costs for treatment, recurrence and reoperation rates at 6 months ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02330159
Study type	Observational
Source	Southeast Clinical Research Associates, Houston, Texas
Contact	Eric M Haas, MD
Phone	7137900600
Email	ehaasmd@houstoncolon.com
Status	Recruiting
Phase	N/A
Start date	February 2015
Completion date	July 2016

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01963273` - Video Assisted Ablation of Pilonidal Sinus	N/A
Completed	`NCT00716937` - Karydakis Procedure Versus Excision With Healing by Secondary Intention (EHSI) in Sacrococcygeal Pilonidal Sinus	Phase 4
Recruiting	`NCT05474911` - PILONIDAL SINUS: CONVENTIONAL CARE VERSUS NEGATIVE PRESSURE THERAPY.	N/A
Completed	`NCT04599517` - The Most Frequently Preferred Surgical Method In The Treatment Of Sacrococcygeal Pilonidal Disease
Recruiting	`NCT02539693` - Sacrococcygeal Local Anesthesia With Different Doses of Clonidine for Pilonidal Sinus Surgery	N/A
Completed	`NCT01081522` - A Preliminary, Non-comparative Study to Evaluate a Bioresorbable Wound Scaffold in Acute Wounds	N/A
Completed	`NCT00997048` - Comparison Between Laying Open and Sinus Excision of Pilonidal Sinus - a Randomized Study	N/A
Not yet recruiting	`NCT04273997` - Metronidazole Ointment in Non-healing Pilonidal Sinus Wounds	Phase 2
Recruiting	`NCT06324656` - The Efficacy of Combining Platelet-rich Plasma With Crystallized Phenol in Pilonidal Sinus Disease	N/A
Completed	`NCT02246192` - Use of Plasma Rich in Growth Factors (PRGF) in Pilonidal Sinus Excision	N/A
Completed	`NCT01662765` - Conservative Versus Surgical Treatment of Umbilical Pilonidal Disease	N/A
Completed	`NCT06206330` - Effect of Platelet Rich Plasma (PRP) on Healing Time in Patients Following Pilonidal Sinus Surgery	N/A
Recruiting	`NCT04217824` - Comparison of Karydakis and Limberg Flap Treatment of Pilonidal Sinus in Adolescent. a Prospective, Randomised Study	N/A
Recruiting	`NCT03483480` - Non-Powered Negative Pressure Wound Therapy vs Open Technique for Pilonidal Disease	N/A
Not yet recruiting	`NCT06140199` - Comparing Minimally Invasive Treatments for Pilonidal Disease: LA POPA Trial (Laser And Pit-picking OR Pit-picking Alone)	N/A
Not yet recruiting	`NCT06286397` - Topical Anti-Androgens in Pilonidal Sinus Disease	Phase 2
Completed	`NCT03923621` - Pilonidal Excision Versus Endoscopic Surgery	N/A
Active, not recruiting	`NCT01792557` - Crystallized Phenol Versus Transposition Flaps for Treatment of Pilonidal Disease: A Prospective Study	N/A
Completed	`NCT02621879` - Bilateral Gluteal Fascio-myo-cutaneous Flap in Treatment of Recurrent Pilonidal Disease	N/A
Completed	`NCT00412659` - Mid-line Excision Versus Karydakis Operation for Pilonidal Sinus	Phase 2/Phase 3